Manipal Health Enterprises / Q1-FY27

MANIPALHEALTHENTERPRISES Q1 FY27 earnings call.

A source-linked concall view: reported numbers, management language, guidance, commitments and risks that should carry forward.

Research layer active

ConCallIQ research layer

Signal, with the source still visible.

Use the controls below to narrow the view, then follow the evidence into the next layer of context.

Positive2026-07-16Back to MANIPALHEALTHENTERPRISES

Revenue

₹3,091 Cr

verified against source

Revenue YoY

38%

reported change

EBITDA

₹749 Cr

latest reported figure

Source

screener in

record provenance

Actual signal trajectory

Where this quarter sits.

source records only
PAT (₹ Cr)PositiveWatchNegative
1 actual records
Actual quarterly PAT (₹ Cr) trajectoryReported values plotted by quarter. Hover or focus a point for its quarter, value, and source sentiment.Q1 FY27: 243 · Positive source sentiment · 2026-07-16Q1 FY27243243
Values are taken from the available verified source records; sentiment color is a separate source-read indicator.

Quarter read

What the record says.

Manipal Health Enterprises delivered a strong Q1 FY27 with revenue of Rs 391 crore growing 38% YoY, driven by robust volume expansion—IP volumes surged 39% and OP volumes 26% YoY. Network EBITDA reached Rs 749 crore (26% growth, or 30% excluding one-off), with margin expansion of 290bps to 24.2%. The company achieved industry-leading ALOS of 2.7 days and raised ARPO to Rs 77,200/day (+9% YoY) excluding Siadri. Key growth drivers include high-acuity Centers of Excellence now comprising 65% of revenue (growing 45%), and digital revenue contributing Rs 710 crore (23% of out-of-hospital earnings). Siadri integration is progressing—EBITDA margin reached 17.5% with 13% revenue growth. The 50th hospital launched in Electronic City, Bangalore with 300 beds, and Kinder Hospital acquisition announced. Capex guidance of Rs 2,000 crore for FY27 with Rs 900 crore already deployed in Q1. Post-IPO debt repayment, net debt/EBITDA will reduce to 0.9x. Key risks include slower-than-expected Siadri margin convergence, government scheme transition in East, and greenfield ramp-up costs. Management expressed confidence in sustaining volume-driven growth trajectory.

Colored figures show movement against the previous available record.

Guidance to track

  • Company has already deployed Rs 900 crore in Q1 alone, front-loading investments. Bed capacity additions include Electronic City (300 beds, Q2), Raipur (Q4), Nashik (103 beds operational).
  • Acquisition of entire business operations of Kinder Hospital in Whitefield, Bangalore for ~Rs 22 crore annual revenue. Facility to be remodeled into multispecialty (8-9 month project), adding 100 beds to existing cluster.
  • Trigger initiated for debt repayment in Q2; current net debt/EBITDA of 2.8x will reduce to 0.9x post-IPO proceeds deployment. Company comfortable operating at 1.5-2x leverage.
  • At 65% occupancy with industry-leading ALOS of 2.7 days, management sees headroom to grow volumes without significant capacity addition in existing hospitals.

Risks flagged

  • Siadri EBITDA margin at 17.5% vs network average of 24-25%—gap of ~750bps. Full integration playbook (16-18 months) yet to complete. Analyst questioned turnaround timeline; management deflected with qualitative responses rather than specific margin targets.
  • East region facing government scheme migration from state to national scheme. Government mix (~14% of institutional revenue) may impact collections. Management acknowledged discussions with authorities ongoing but no clarity on timeline or impact quantification.
  • Two greenfield hospitals in Bangalore (Kannapura, Alanka) causing ~5% network doctor cost impact. Kannapura broke even at month 5, Alanka at month 2—both ahead of plan at 13% EBITDA margin but still below network average.
  • Q1 collections from scheme patients slower across sector, impacting cash flow timing. Management expects improvement as year progresses through collection cycles. Not quantified.

Key quotes

  • We believe that volume growth is a sustainable option for growth in care delivery, not really looking at the price growth—that's been the Manipal philosophy.
  • The Q1 trends are not one-off trends, these are fairly secular tailwinds that we see for Manipal. Without guiding to a specific number, these are the tailwinds that we have as we head into subsequent quarters.
  • The dip between last year to this year is not something we are really concerned about. It is not a dip in terms of any operational issues—it is not a dip which to our mind is a sustainable situation. These are two one-offs.

Research modules

Go one layer deeper.